Kyle Rosenke

2.9k total citations
57 papers, 1.4k citations indexed

About

Kyle Rosenke is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Kyle Rosenke has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 19 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Kyle Rosenke's work include Viral Infections and Outbreaks Research (23 papers), Viral Infections and Vectors (19 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Kyle Rosenke is often cited by papers focused on Viral Infections and Outbreaks Research (23 papers), Viral Infections and Vectors (19 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Kyle Rosenke collaborates with scholars based in United States, Canada and United Kingdom. Kyle Rosenke's co-authors include Heinz Feldmann, Elizabeth A. Fortunato, David Safronetz, Friederike Feldmann, Min Luo, Greg Saturday, Atsushi Okumura, Elaine Haddock, Michael A. Jarvis and Kimberly Meade‐White and has published in prestigious journals such as Nature Communications, Journal of Virology and Scientific Reports.

In The Last Decade

Kyle Rosenke

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Rosenke United States 20 845 516 250 128 121 57 1.4k
Lián Dŏng United States 12 1.0k 1.2× 442 0.9× 284 1.1× 185 1.4× 361 3.0× 14 1.5k
Peggy Möller Germany 13 984 1.2× 395 0.8× 237 0.9× 92 0.7× 279 2.3× 15 1.3k
Greg Saturday United States 22 1.4k 1.6× 399 0.8× 162 0.6× 173 1.4× 123 1.0× 62 1.8k
Viktoriya Borisevich United States 28 1.7k 2.0× 1.1k 2.1× 298 1.2× 286 2.2× 140 1.2× 76 2.2k
Russell R. Bakken United States 21 1.1k 1.4× 446 0.9× 225 0.9× 325 2.5× 123 1.0× 36 1.5k
Priya Luthra United States 22 986 1.2× 562 1.1× 429 1.7× 220 1.7× 541 4.5× 29 1.7k
Joshua C. Johnson United States 23 1.7k 2.0× 606 1.2× 353 1.4× 126 1.0× 198 1.6× 46 2.1k
Nicole L. Garza United States 19 1.1k 1.3× 459 0.9× 378 1.5× 159 1.2× 132 1.1× 25 1.6k
Ingelise J. Gordon United States 14 610 0.7× 405 0.8× 235 0.9× 204 1.6× 337 2.8× 17 1.1k
Laura Bollinger United States 14 674 0.8× 243 0.5× 193 0.8× 106 0.8× 52 0.4× 31 941

Countries citing papers authored by Kyle Rosenke

Since Specialization
Citations

This map shows the geographic impact of Kyle Rosenke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Rosenke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Rosenke more than expected).

Fields of papers citing papers by Kyle Rosenke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Rosenke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Rosenke. The network helps show where Kyle Rosenke may publish in the future.

Co-authorship network of co-authors of Kyle Rosenke

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Rosenke. A scholar is included among the top collaborators of Kyle Rosenke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Rosenke. Kyle Rosenke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hawman, David W., Thomas Tipih, Edgar A. Hodge, et al.. (2025). Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice. Nature Communications. 16(1). 655–655. 4 indexed citations
2.
Tipih, Thomas, Claude Kwe Yinda, Atsushi Okumura, et al.. (2025). Highly pathogenic avian influenza H5N1 clade 2.3.4.4b genotype B3.13 is highly virulent for mice, rapidly causing acute pulmonary and neurologic disease. Nature Communications. 16(1). 5738–5738. 1 indexed citations
3.
Prévost, Jérémie, Nikesh Tailor, Geoff Soule, et al.. (2025). CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. JCI Insight. 10(22).
4.
Zhou, Shuntai, Nathan Long, Kyle Rosenke, et al.. (2024). Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations. The Journal of Infectious Diseases. 230(6). 1380–1383. 3 indexed citations
5.
Clancy, Chad S., Kimberly Meade‐White, Carl Shaia, et al.. (2023). Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster. Veterinary Sciences. 10(9). 536–536. 1 indexed citations
6.
Safronetz, David, Kyle Rosenke, Angela Sloan, et al.. (2022). Temporal analysis of Lassa virus infection and transmission in experimentally infected Mastomys natalensis. PNAS Nexus. 1(3). pgac114–pgac114. 6 indexed citations
7.
Rosenke, Kyle, Friederike Feldmann, Eric Bohrnsen, et al.. (2022). Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques. JCI Insight. 8(4). 24 indexed citations
8.
Matson, M. Jeremiah, Emily Ricotta, Friederike Feldmann, et al.. (2022). Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study. The Lancet Microbe. 3(7). e533–e542. 5 indexed citations
9.
Hansen, Frederick, Kimberly Meade‐White, Chad S. Clancy, et al.. (2022). SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Cell Reports. 38(11). 110515–110515. 12 indexed citations
10.
Rosenke, Kyle, Atsushi Okumura, Matthew Lewis, et al.. (2022). Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. JCI Insight. 7(13). 25 indexed citations
11.
Lingas, Guillaume, Kyle Rosenke, David Safronetz, & Jérémie Guedj. (2021). Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin. PLoS Computational Biology. 17(1). e1008535–e1008535. 23 indexed citations
12.
Hansen, Frederick, Michael A. Jarvis, Heinz Feldmann, & Kyle Rosenke. (2021). Lassa Virus Treatment Options. Microorganisms. 9(4). 772–772. 18 indexed citations
13.
Rosenke, Kyle, Shanna Leventhal, Hong M. Moulton, et al.. (2020). Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers. Journal of Antimicrobial Chemotherapy. 76(2). 413–417. 17 indexed citations
14.
Funnell, Simon G. P., William E. Dowling, César Muñoz‐Fontela, et al.. (2020). Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nature Communications. 11(1). 4253–4253. 37 indexed citations
15.
Ranadheera, Charlene, Emelissa J. Valcourt, Bryce M. Warner, et al.. (2020). Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis. Scientific Reports. 10(1). 12378–12378. 67 indexed citations
16.
Nuismer, Scott L., Christopher H. Remien, Tanner J. Varrelman, et al.. (2020). Bayesian estimation of Lassa virus epidemiological parameters: Implications for spillover prevention using wildlife vaccination. PLoS neglected tropical diseases. 14(9). e0007920–e0007920. 10 indexed citations
17.
Tang-Huau, Tsing-Lee, Heinz Feldmann, & Kyle Rosenke. (2019). Animal models for Lassa virus infection. Current Opinion in Virology. 37. 112–117. 11 indexed citations
18.
Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2018). Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Research. 157. 18–26. 60 indexed citations
19.
Rosenke, Kyle, et al.. (2016). Endogenous retroviruses mobilized during friend murine leukemia virus infection. Virology. 499. 136–143. 6 indexed citations
20.
Safronetz, David, Chad E. Mire, Kyle Rosenke, et al.. (2015). A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses. PLoS neglected tropical diseases. 9(4). e0003736–e0003736. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lián Dŏng Breakdown of academic impact, for papers by Peggy Möller Breakdown of academic impact, for papers by Greg Saturday Breakdown of academic impact, for papers by Viktoriya Borisevich Breakdown of academic impact, for papers by Russell R. Bakken Breakdown of academic impact, for papers by Priya Luthra Breakdown of academic impact, for papers by Joshua C. Johnson Breakdown of academic impact, for papers by Nicole L. Garza Breakdown of academic impact, for papers by Ingelise J. Gordon Breakdown of academic impact, for papers by Laura Bollinger
Rankless by CCL
2026